Article thumbnail

Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations

By K Korfi, S Ali, JA Heward and J Fitzgibbon

Abstract

K Korfi, S Ali, J Heward and J Fitzgibbon are supported by Cancer Research UK Programme Grant [C15966/A15968] and Bloodwise Programme Grant [15002]. S Ali is also a recipient of Cancer Research UK Clinical Careers Committee research bursary [C56515/A21397]

Topics: Epigenetic mutations, epigenetic therapies, EZH2 inhibitors, follicular lymphoma, HDAC inhibitors
Publisher: 'Informa UK Limited'
Year: 2017
DOI identifier: 10.1080/15592294.2017.1282587
OAI identifier: oai:qmro.qmul.ac.uk:123456789/19089
Journal:

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles